Related Experiment Video
Updated: Nov 11, 2025

Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
[Chinese experts suggestions on the application of esmolol injections in patients with arrhythmia]
Abstract:
β-receptor blocker is the cornerstone for the treatment of many cardiovascular diseases. Esmolol, an ultra-short-acting intravenous β-receptor blocker, is characterized with rapid onset of action, a fast metabolism process and convenience in adjusting its effect. It is an important drug in the treatment of acute arrhythmia. By blocking sympathetic excitation, esmolol has other multiple effects, such as negative inotropic action, negative chronotropic action, lowering blood pressure etc. Relative contraindications of its application may occur in clinical practice. Thus, it is of great necessity to master the indications and contraindications for the standard prescriptions and rational administration of the drug.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
06:47Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction
Published on: July 25, 2025
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias